Skip to main content
. 2021 Oct 19;21:1079. doi: 10.1186/s12879-021-06747-8

Table 5.

Susceptibilty of KPC-K.pneumoniae blood isolates determined by broth microdilution according to 2019 EUCAST breakpoints (38)

Period 1 Period 2
N of blood isolates 18 16
MIC range (mg/L) N(%) of susceptible isolates MIC range (mg/L) N (%) of susceptible isolates
Colistin 0.25–32 11 (67) 0.5–4 14 (87.5)
Tigecycline 2–8 0 0.5–2 8 (50)
Gentamicin 1.5– >256 8 (44) 1– >8 8 (50)
Ceftazidime-avibactam 0.5/4–8/4 18 (100) 0.5/4–8/4 16 (100)
Meropenem  > 32 0  > 32 0
Imipenem  > 32 0  > 32 0
Ertapenem  > 32 0  > 32 0